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ABSTRACT
The Protein Data Bank in Europe (http://pdbe.org)
accepts and annotates depositions of macromolec-
ular structure data in the PDB and EMDB archives
and enriches, integrates and disseminates structural
information in a variety of ways. The PDBe web-
site has been redesigned based on an analysis of
user requirements, and now offers intuitive access
to improved and value-added macromolecular struc-
ture information. Unique value-added information in-
cludes lists of reviews and research articles that cite
or mention PDB entries as well as access to fig-
ures and legends from full-text open-access publi-
cations that describe PDB entries. A powerful new
query system not only shows all the PDB entries that
match a given query, but also shows the ‘best struc-
tures’ for a given macromolecule, ligand complex
or sequence family using data-quality information
from the wwPDB validation reports. A PDBe REST-
ful API has been developed to provide unified ac-
cess to macromolecular structure data available in
the PDB and EMDB archives as well as value-added
annotations, e.g. regarding structure quality and up-
to-date cross-reference information from the SIFTS
resource. Taken together, these new developments
facilitate unified access to macromolecular structure
data in an intuitive way for non-expert users and sup-
port expert users in analysing macromolecular struc-
ture data.
INTRODUCTION
The Protein Data Bank in Europe (PDBe; http://pdbe.org;
1) is actively involved in managing three core archives in
molecular and cellular structural biology. It is a founding
member of the Worldwide Protein Data Bank (wwPDB;
http://wwpdb.org; 2), the organisation that manages the
Protein Data Bank (PDB), the global archive of 3D atom-
istic biomacromolecular structures. The wwPDB partners
share responsibility for the annotation of macromolecular
structure depositions to the PDB with PDBe being respon-
sible for the annotation of all European and African de-
positions. In the period January to August 2015, the PDBe
team annotated over 35% of all the depositions to the PDB.
In 2002, PDBe established the Electron Microscopy Data
Bank (EMDB; 3) to archive macromolecular structure vol-
umes determined using electron cryo-microscopy (3DEM)
and tomography. EMDataBank (emdatabank.org; 4), an in-
ternational consortium of which PDBe is a founding mem-
ber, now manages the EMDB. In 2014, PDBe established
the Electron Microscopy Pilot Image Archive (EMPIAR;
http://pdbe.org/empiar), an archive that stores raw image
data for a number of entries in EMDB.
Since the turn of the century, the PDB archive has grown
rapidly and now contains more than 110 000 experimen-
tally determined atomic structures. From very early on, with
the atomic structure of the DNA double helix (5–7) and the
first protein structures of haemoglobin andmyoglobin (8,9),
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to more recently with structures of ribosomes (10,11) and
GPCRs (12), structural biology has provided profound in-
sights that aid our understanding of protein structure, evo-
lution, function and their relation to amino-acid sequence.
The archiving of atomic structures in the PDB has facili-
tated the emergence of structural bioinformatics as a field
of scientific endeavour and has led to the development of
successful methods for the prediction of protein structures
(13,14), design of macromolecular inhibitors with potential
therapeutic use (15) and design of new protein molecules
with desired properties (16).
Unfortunately, due to the complex nature of 3D struc-
tural data, users with a limited background or training in
structural biology (such as biochemists, molecular biolo-
gists, geneticists, medicinal chemists, physicians) do not al-
ways find it easy to exploit the rich information content of
the structural archives (PDB and EMDB) to help them an-
swer their research questions. It is for archive keepers such
as PDBe and the wider structural bioinformatics commu-
nity to address this challenge and develop newways of mak-
ing structural information more easily accessible and rele-
vant to these user communities (17,18). The rapid increase
of the typical size and complexity of themolecules and com-
plexes studied poses challenges even for expert users. It is
therefore necessary for structural bioinformatics resources
to try and understand the evolving requirements of the user
communities and to develop innovative methods to address
those requirements. In the past few years, PDBe has carried
out extensive user studies and identified major challenges
faced by experts and non-experts alike:
1. How to obtain accurate, relevant, non-redundant and
up-to-date information on macromolecular structure
data available in the PDB and EMDB archives?
2. How to assess the quality of models and data, especially
when more than one structure is available for a molecule
or system of interest?
3. How to understand complex 3D structural data and to
use structural information to answer pertinent research
questions or to formulate new research hypotheses?
The user study also highlighted an urgent need for inno-
vative methods to make structural data easier to discover
and understand:
1. Better methods to querymacromolecular structure data,
that provide an easy way to identify the best ormost rele-
vant structure available in the PDB in a given query con-
text;
2. Better ways to display complex 3D structural data using
interactive tools that make it easier for users to under-
stand such data.
Addressing these challenges requires continuous im-
provements to existing tools and services as well as the de-
velopment of entirely new tools and data-analysis meth-
ods. Over the past decade, PDBe has developed a variety
of tools and services to help users find and exploit struc-
tural data, e.g. PDBeXplore (19), UniPDB (19), PDBePISA
(20), PDBeMotif (21) and PDBeFold (22). In collaboration
with the UniProt team, PDBe also maintains SIFTS (23), a
resource which links structures in the PDB and sequences
archived by UniProt (24) and thereby allows for easy trans-
fer of annotations between the sequence and structure data
resources. The information available in SIFTS is central
to integrating structural information with other biological
data and is used by the wwPDB partners (PDBe, RCSB,
25 and PDBj, 26) and many other structural bioinformat-
ics resources (e.g. CATH, 27, SCOP, 28, Pfam, 29, InterPro,
30, Reactome, 31) as well as a variety of academic research
teams. The additional annotations available from SIFTS
are now integrated in visualisation tools such as JSmol
(http://www.jmol.org/) and JalView (32). These and other
visualisation tools such as OpenAstexViewer (33), PyMOL
(www.pymol.org) and Chimera (34), and interactive web-
based interfaces (e.g. Vivaldi, 35) are important for making
analysis and visualisation of 3D structural data more acces-
sible for non-expert and expert users alike.
These efforts, alongside the archive-remediation work by
thewwPDBpartners to improve the quality and consistency
of the data in the PDB archive (36), have helped PDBe to
improve the data-discoverymechanism.Additionally, query
systems have been enriched by incorporating value-added
annotation from SIFTS and other chemical and biomedi-
cal resources such as ChEMBL (37) and DrugBank (38),
and genomic information such as gene names and homol-
ogous protein information from the Homologene resource
(http://www.ncbi.nlm.nih.gov/homologene). All these im-
provements help to address the problem of finding infor-
mation in the PDB that is relevant to many types of queries
by reducing the false-positive rate. For all search systems to
date, the fundamental unit of information remains a PDB
entry rather than the specific biological molecule or assem-
bly studied in a given experiment. As a consequence, with
the growth of the PDB beyond 110 000 structures, the re-
sult sets may include long lists of PDB entries, and their use
and analysis becomes time-consuming, as users may have to
manually sort through them. To address this issue, it is nec-
essary to radically improve the ways in which macromolec-
ular structure data can be queried and to provide mech-
anisms for basic analysis of result sets, e.g. by identifying
a representative (or ‘best’) structure for every molecule or
complex (instead of a long list of duplicates, variants, mu-
tants and complexes), by making it easy to narrow down
search results, by providing additional ways of displaying
results other than long lists of entries and by displaying key
summary information for each entry in an intuitive manner.
Here we describe the results of recent efforts at PDBe to
improve the accessibility of macromolecular structure data
(‘redesign project’) by:
 Improving the quality of the metadata of entries in the
PDB archive;
 Adding annotations and value-added information to
provide a biological context for all structural data in the
PDB;
 Enhancing data accessibility by developing a RESTful
API to provide unified access to all macromolecular
structure data;
 Addressing issues related to the data-query mechanism
and basic analysis of search results;
Nucleic Acids Research, 2016, Vol. 44, Database issue D387
 Redesigning the web pages based on user-centric design
principles and understanding of user requirements.
IMPROVING METADATA QUALITY
Since 2003, the wwPDB partners have carried out a num-
ber of extensive archive-remediation projects to advance
the quality, consistency and integrity of the information
present in the PDB (36), and they continue to improve the
archive, for instance through enhancing the representation
of small molecule data (especially peptidic antibiotics and
inhibitors, 39). These efforts have resulted in better data
quality and have also led to improved annotation prac-
tices. Such remediation, however, is an on-going and labour-
intensive process. In the redesign project described here,
PDBe has addressed several additional data-consistency is-
sues (Table 1) and a number of user requests such as mak-
ing information on intramolecular connectivity available as
part of the entry description and having consistent repre-
sentation of ligand-binding data. These enhanced data are
loaded into PDBe’s Oracle database that powers the PDBe
services and web pages. Enhancing the data quality in the
archive PDBx/mmCIF files and making that information
available via the central database ensures that all PDBe ser-
vices provide users with improved and consistent informa-
tion.
VALUE-ADDED INFORMATION
Integrating PDB data with information from other bio-
logical data resources has long been a priority for PDBe.
More than a decade ago, these efforts resulted in the
SIFTS resource which continues to provide up-to-date
cross-reference information between PDB and UniProt.
This information has made it possible to develop an au-
tomated procedure to obtain consistent names for the pro-
tein molecules across the PDB archive, based on the rec-
ommended names, other names and feature-table informa-
tion available in UniProt. Only if there is no UniProt cross-
reference available are the macromolecule names from the
PDB entry used. SIFTS information has also made it possi-
ble to provide information on gene names and homologous
proteins, derived from UniProt and Homologene.
PDB annotation includes the ‘quaternary structure’ or
the predicted assembly of the macromolecules in the crys-
tal. The assemblies are predicted using PISA (20), which
was developed jointly by PDBe and CCP4 (40). When pre-
dicting possible assemblies, PISA calculates additional in-
formation including the accessible and buried surface areas,
interacting residues in the interface(s) of multimeric assem-
blies and binding energies. These types of information are
very valuable when studying protein–protein interactions.
As part of the redesign project, every assembly annotated
in the PDBx/mmCIF file of a PDB entry is explicitly gen-
erated and the PISA information for it is stored. A succinct
textual description of the assembly composition is also de-
rived automatically, e.g. ‘protein structure’ for monomers
and homomeric oligomers; ‘protein–protein complex’ for
heteromeric complexes containing only proteins; ‘DNA–
Protein complex’ or ‘RNA–Protein complex’, etc.
The recent adoption of PDBx/mmCIF as the princi-
pal distribution format for the PDB archive has brought
about many improvements in the way in which macro-
molecular structures can be represented. For instance, with
PDBx/mmCIF it is possible to represent large structures,
such as complete ribosomes, in a single file. The file for-
mat is extensible and thus allows for local extensions en-
riching the information available in these files. At present,
the PDBx/mmCIF files in the PDB archive do not contain
any connectivity and bond-order information for any of the
standard or non-standard residues and bound molecules.
This poses a challenge for molecular graphics software
(and other software that needs to ‘perceive’ the chem-
istry of entities), as these usually only store the connec-
tivity of standard residues. As part of the new develop-
ments at PDBe, the information describing non-standard
residues, small molecules and their binding sites has been
improved across the archive, by adding connectivity and
binding-site information in a consistent way for all non-
standard small molecules present in the PDB entry. This
information is then made available to all PDBe services
through its database. We have further modified the Ope-
nAstexViewer to read the connectivity information directly
from PDBx/mmCIF files to allow for better graphic pre-
sentation of small molecules. The information is also used
to produce static images for the PDBe entry pages (us-
ing PyMOL version 1.6) that accurately portray the small
molecule connectivity. The updated PDBx/mmCIF files are
available through the PDBe entry pages.
As part of the wwPDB collaboration, PDBe has imple-
mented a validation pipeline (41) based on the recommen-
dations of the X-ray Validation Task Force (VTF) (42). The
pipeline has been in production at all wwPDB sites since
August 2013 and a validation report for every PDB entry
solved by X-ray crystallography is made available in PDF
format via thewwPDBFTP sites. Additionally, detailed val-
idation information is made available in XML format via
the same sites. The XML data are loaded into the PDBe
database and thus available to all PDBe services and web
pages. One of the major recommendations of the wwPDB
X-ray VTF was to produce percentile plots for a number
of key validation-related parameters for every entry (42).
While these plots are displayed on the new PDBe entry
pages, a more compact representation is also needed that
provides a uniform, condensed, at-a-glance impression of
the quality of structures. Such a combined quality measure
can be calculated by aggregating quality information re-
garding the model on the one hand and the fit of the model
to the experimental data on the other. In practice, the com-
binedmodel-quality measure is the harmonic average of the
percentile scores for the applicable model-quality indicators
(such as clash-score (43), percentage of residues classified
as Ramachandran outliers and rotamer outliers), whereas
the agreement between model and data is represented by
the harmonic average of the Rfree and RSR-Z outlier per-
centile scores. (If no experimental data were deposited, the
overall quality score is reduced by half.) The harmonic aver-
ages are graphically ‘blurred’ so as not to suggest too high a
degree of numerical precision/accuracy (it is unlikely that
the quality of a structure with a harmonic average score
of 85% is significantly different from one with a value of
80% or 90%, so such scores are made visually indistinguish-
able). The resulting representation is compact enough to be
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Table 1. A list of PDBx/mmCIF data items that are made consistent in all entries in the PDB archive before the data are loaded into the PDBe database.
The second column summarises the changes made to each data item to make it consistent
struct ref seq dif.details Describes the observed differences between a residue in the PDB and corresponding
residue in reference database (e.g. UniProt for protein molecules)
exptl.method Describes the experimental methods used to determine the 3D structure.
diffrn source.source The radiation source used to carry out the diffraction experiment, e.g. ‘Rotating anode’
citation.journal abbrev The abbreviated name of the cited journal
diffrn radiation.pdbx diffrn protocol Diffraction protocol used, e.g. ‘Single wavelength’, ‘MAD’ etc.
diffrn detector.detector The type of detector used in the diffraction experiment
computing.structure refinement Software used for refinement of the structure
symmetry.space group name H-M Space group symmetry
shown by many PDBe services to highlight the quality of
individual PDB entries (Figure 1). Finally, a single qual-
ity indicator is also calculated for each entry by taking the
harmonic average of all the percentile scores representing
model and model-data-fit quality measures and then sub-
tracting 10 times the numerical value of the resolution (in
A˚ngstro¨m) of the entry to ensure that resolution plays a
role in characterising the quality of a structure. This sin-
gle empirical ‘quality measure’ value is used by the PDBe
query system to sort results and identify the ‘best’ structure
in a given context. At present, entries determined by meth-
ods other than X-ray crystallography do not have similar
data quality information available and are not considered
as ‘best structures’.
Usually, the only way to obtain information about the
goals of structural studies and the biological insights gained
from them is to access the publication alongside the de-
posited data available in the various archives, since relatively
little biological information about the biological goals and
results of a structure determination is captured as part of
PDB deposition or annotation. Accessing relevant publi-
cations that cite or mention a given PDB entry can fur-
ther contribute to the understanding of the biological rel-
evance of a given structure. Locating the publication in
Europe PMC (http://europepmc.org/) or PubMed (http://
www.ncbi.nlm.nih.gov/pubmed) allows users to identify all
relevant publications that cite it, but it ismuchmore difficult
to find publications thatmention a PDB code but do not ref-
erence the paper in which it was described.Moreover, about
one in six PDB entries are never published at all and hith-
erto identifying publications that cite such structures has
been almost impossible. To address these problems, PDBe
has collaborated with the Europe PMC team at EMBL-
EBI to identify through text mining (of full-text, open ac-
cess) publications that mention PDB codes but do not re-
fer to any publication describing the PDB entry. Moreover,
through Europe PMC, PDBe now has access to all the fig-
ures and figure legends for full-text open-access publica-
tions describing PDB entries.
The value-added information described in this section is
loaded into the PDBe database and the next section de-
scribes various ways in which it is made accessible to PDBe
users, tools and services.
IMPROVING DATA DISSEMINATION
With improved data quality and value-added information
now available, PDBe has developed ways to make these ac-
cessible with a focus on two major communities:
1. User communities that require programmatic access to
structural and structure-related information (e.g. bioin-
formaticians and chemoinformaticians).
2. Non-experts, experts and occasional users of the PDB
who require access to this information via the web and
who may only be interested in a single entry.
To support these two distinct use cases we have developed
a RESTful API and new web-based entry pages as well as a
powerful new query system, which can be accessed via the
RESTful API or a web interface.
PDBe RESTful APPLICATION PROGRAMMING IN-
TERFACE (API)
The RESTful API (http://pdbe.org/api) was designed to
provide programmatic access to all information in the PDBe
database. This includes information available in the PDB
and EMDB archives, but also the improved and value-
added information described above. The API also makes
information from other PDBe tools and services (such
as PISA) programmatically available. For easy access, the
API contains separate modules for PDB, EMDB, SIFTS,
PISA and validation information with relevant calls aggre-
gated in each module. This allows for easy integration of
all macromolecular structure information into an applica-
tion or workflow. The API also makes it possible to access
structure-related information in manageable data blocks
without having to read large files or parse data that is not
relevant.
The data sources underlying the API are updated weekly
and the API is tested extensively with every week’s release
of new data into the archives. Importantly, the API is in-
tegrated in the PDBe production workflow and supports
the redesigned PDB and EMDB entry pages. This ensures
that the API is reliable, stable and provides up-to-date infor-
mation. The API has been integrated in Jmol/JSmol where
it is used to show value-added annotations from SIFTS as
well as validation-related information. JalView has also in-
tegrated the API to provide its users with a facility to query
PDB data and to provide additional value-added informa-
tion for individual PDB entries. We envision the PDBe API
to be a long-term, stable, well-tested resource that powers
traditional and novel applications based on 3D structural
information.
ENTRY PAGES
The PDBe entry pages that provide information for every
PDB and EMDB entry have been completely redesigned
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Figure 1. An example of an entry summary page showing the organisation into three main areas (highlighted with dashed lines). The top panel shows the
essential details and access to a picture gallery. The right-hand panel contains ‘Quick links’ to pages with more detailed information, file downloads and
3D viewer. It is also used to provide other relevant information, e.g. if the entry has been cited or mentioned in reviews or other articles. The main body of
the page is divided into four sections as described in the text, providing summary information and links to the detailed pages for each of the sections.
following an extensive user survey, user testing and feed-
back to facilitate intuitive and easy data accessibility. PDB
and EMDB entry pages now have the same organisation
and layout, making it easier for users to access data in both
archives. By following best practices for ‘responsive design’,
we have also ensured that the pages and all the newly devel-
oped tools have a user-friendly interface on different devices
such as desktops, tablets and smartphones.
The summary page for an entry is organised in threemain
areas as shown in Figure 1. The top of the page provides
succinct information about structure quality, experimental
method(s), entry title and the publication that describes the
structure. It also provides access to a picture gallery con-
taining a variety of images of the deposited entry and the
macromolecular assembly. The right-hand side of an entry
page contains ‘Quick links’ to pages with more detailed in-
formation, file downloads, etc. as well as other information
that is relevant in the context of the entry and the page.
For example, on a summary page of a PDB entry there are
pointers to reviews that cite that PDB entry as well as to pa-
pers that mention the PDB entry but do not cite the original
publication.
The remainder of the page is divided into four panels
that provide summary information about important cate-
gories of information regarding the structure and provide
links that enable the user to ‘drill down’ to obtain more de-
tails. The content of the four panels is based on analysis
of a study we carried out with users from different back-
grounds and specialisations, including biochemists, struc-
tural biologists, clinicians, geneticists and others, from both
academia and industry. These users were provided with sev-
eral dozen cards that each contained the name of a con-
cept or information item that is available for (many) PDB
entries, e.g. ‘structure quality’, ‘assembly’, ‘biological func-
tion’, ‘sequence domain’. The users were asked to link con-
cepts that they considered to be related. The resulting links
were subjected to cluster analysis and clearly revealed four
major clusters of concepts that describe how users think
about structures: ‘Function and Biology’, ‘Ligands and En-
vironments’, ‘Structure analysis’ and ‘Experiment and Val-
idation’. Each of these four categories is represented in a
separate panel, and additional information for each can be
obtained through one or more levels of detail pages. An ad-
ditional detail page brings together information on the lit-
erature related to the entry.
Thus, there are five types of entry-detail pages that con-
tain the following information for a given entry:
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1. Citations––The citation page shows the publication that
describes the PDB entry. It also shows the figures and
legends from the primary citation if the publication is
‘full-text open access’. In addition, the page lists reviews
and articles that cite or mention the PDB code of the en-
try, thus helping users to discover relevant publications.
2. Structure analysis––The structure analysis page lists all
the assemblies (quaternary structures) annotated for the
PDB entry. The PDB assemblies have been analysed by
PISA and, where available, a summary of information
on each assembly is listed (such as accessible and buried
surface area and calculated dissociation energy). This
page also lists each unique macromolecule and asso-
ciated cross-reference information to structure and se-
quence family databases such as gene names,UniProt ac-
cessions, etc. The page contains an interactive sequence-
feature viewer that shows annotations mapped onto
the sequence of each individual molecule. Additionally,
there are links to detail pages that describe each indi-
vidual macromolecule and contain interactive viewers to
help users understand their 3D structure.
3. Function and Biology––This page addresses the biolog-
ical relevance of the structure. It includes information
about the biological process, function and cellular loca-
tion based on the Gene Ontology (GO) (44) assignments
provided by SIFTS. For enzymes, information is shown
on the reaction catalysed and other relevant comments
on function or biological availability of the particular en-
zyme obtained from enzyme resources such as IntEnz
(45), Brenda (46) and Expasy (47). The page also con-
tains information on sequence (Pfam; 29) and structure
domains (CATH; 27 and SCOP; 28) and has a gallery of
images that depict the assemblies and themapping of the
sequence and structure domains onto the 3D structure.
4. Ligands and Environments––For each unique bound
molecule, there is a page with general information about
the molecule, and a 2D and optional 3D view of the en-
vironment where each instance of the molecule is bound.
The 2D representation of the binding site uses the pro-
gram LigPlot (48) from PDBsum (49).
5. Experiment and Validation––This page lists experiment-
related information provided by the depositor and a
summary of data that can help users assess the quality
of the structure. The quality information is taken from
the corresponding wwPDB validation report (42).
Images of the PDB entry or the assembly are a very effec-
tive way not only to provide a simple view of the molecule
but also to convey information and provide additional in-
sights into the structure, e.g.
 Identifying a single macromolecule in the assembly;
 Identifying the number of unique macromolecules that
are present in a complex;
 Showing the overall shape of a complex;
 Depicting annotation such as sequence or structure do-
mains on the macromolecular structure.
To facilitate such insights, visualisation programs need to
understand what the unique small molecules and macro-
molecules are in a PDB entry so that they can be high-
lighted individually. PDBe has worked closely with the Py-
MOL developers at Schro¨dinger to implement additional
functionality in PyMOL. Figure 2 shows examples of im-
ages coloured by unique molecules or annotations that can
help users to understand complex structure data.
A number of interactive tools have been incorporated
into the PDBe web pages to help users analyse macro-
molecules and ligands in PDB entries. An example of a page
that describes each unique macromolecule in a given entry
is shown in Figure 3. This page, linked from both the ‘Struc-
ture analysis’ and ‘Summary’ pages (as ‘Molecule details’),
provides summary information, including the name of the
macromolecule, its sequence in FASTA format, gene name,
source organism and expression system. It also contains a
gallery of pictures highlighting the given macromolecule in
the ‘preferred’ assembly or complex as well as highlighting
all the sequence (Pfam) and structure domains (SCOP and
CATH). The page contains three interactive viewers that
present information on 1D (sequence-feature viewer), 2D
(topology viewer) and 3D structure (using JSmol; Figure 3).
For each chain, the sequence-feature view shows the sam-
ple sequence studied and depicts value-added annotation
fromSIFTS including residue-levelmapping toUniProt, se-
quence families (Pfam), structure domains (SCOP, CATH),
binding-site residues, structure quality and the secondary
structure. By default the sequence-feature view shows the
chain that has the maximum number of observed residues.
The same chain is also shown in the topology viewer, which
depicts the helices and strands in a 2D representation that
takes into account the interactions of these secondary struc-
ture elements, leading to a consistent display of sheets and
domains in the structure. JSmol is used for interactive dis-
play of the 3D structure. The three viewers are linked and
selecting a feature in the sequence or topology view shows
the same in the other two views including the 3D structure
view in JSmol. The interactive topology view helps users
link (and understand) sequence-based annotation to the 3D
molecular structure view.
IMPROVED QUERY MECHANISM
There are many query systems available for PDB data, both
at wwPDB partner sites and at other structural bioinfor-
matics resources such as PDBsum and OCA (http://oca.
weizmann.ac.il). These query systems usually include infor-
mation annotated in the PDB entries and value-added in-
formation (e.g. from SIFTS) or cross-references and value-
added information from other resources such as ChEMBL,
UniProt and Drugbank or genome information from En-
sembl (50). Each query system has its unique features,
strengths and weaknesses, but they all typically present the
results of a query as a list of PDB entries. This is useful for
an expert user who can deal with a large number of PDB en-
tries, but for a non-expert it can be confusing when a num-
ber of PDB entries are listed for essentially the same protein
(e.g. Human carbonic anhydrase 2 features in 541 entries as
of 17 September 2015). The problem is compounded by the
fact that it is not easy to assess and compare the quality
of such sets of related structures. One way to alleviate this
problem is to have ‘facets’, i.e. a facility that allows users to
drill down to a single or a manageable number of PDB en-
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Figure 2. (A) Image highlighting the location of the six copies of globin d (blue) within the giant haemoglobin complex from Glossoscolex paulistus. PDB
entry 4u8u. (B) The human rhinovirus capsid (PDB entry 4rhv) contains 60 copies each of four different proteins: VP1 (green), VP2 (yellow), VP3 (blue)
and VP4 (cyan). (C) The location of the eight copies of Pfam domain ‘Pumilio-family RNA binding repeat’ is highlighted in this image of Human Pumilio
1 protein, PDB entry 3bsx.
tries based on other filtering criteria such as ‘organism’, ‘se-
quence or structure domain’, ‘resolution’, etc. Many query
systems also offer an ‘autocomplete’ feature that helps nar-
row down the search by providing useful matching terms as
users type their query. This usually reduces results sets to a
more manageable number of PDB entries with fewer false
positives, but users still have to assess all entries to select
the one(s) most suitable for their purposes. Moreover, such
features still do not support queries such as:
1. Find all the structures for a given class of macro-
molecules (e.g. kinases) in the PDB and identify the best
structure for each unique macromolecule;
2. Identify all proteins and small molecules in the PDB
which have been observed to interact with a given pro-
tein;
3. List all organisms from which structures for a particular
protein are available;
4. Generate a list of all unique proteins that contain a given
Pfam domain and have structures in the PDB, with the
best representative PDB entry for each unique Pfam do-
main and protein combination;
5. Identify the best structure, based on validation informa-
tion, for a given protein amongst many available in the
PDB.
The new PDBe query system contains several features
available in existing systems (such as providing facets and
autocomplete), but also allows for some basic analysis of
result sets (such as identifying the best structure or the num-
ber of unique proteins in a set) and thus supports the types
of query listed above. This is accomplished by offering dif-
ferent ways to present the results, e.g. as a simple list of
PDB entries (‘Entries view’), or as a list of unique macro-
molecules found in the result set, and by identifying the
best PDB entry (based on the combined quality criterion
described earlier) for each unique macromolecule (‘Macro-
molecules view’), a list of the best available PDB entries for
each macromolecule that binds to a given small molecule in
the result set (‘Compounds view’), or a list of the best PDB
entries for each protein family in the result set (‘Protein
families’ view). Figure 4 shows a ‘Macromolecules view’ for
the results of the query ‘transferases’ selected from the en-
zyme category in the autocomplete suggestions, listing the
best structure for each of the 2262 unique molecules in the
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Figure 3. Interactive visualisation tools displaying annotations for each individual protein molecule. The figure shows the Pfam domain (PF00198: 2-
oxoacid dehydrogenases acyltransferase (catalytic domain)) in protein molecule ’Dihydrolipoyllysine-residue acetyltransferase component of pyruvate
dehydrogenase complex’ (PDB entry 1dpb) highlighted in the sequence feature view (1D), topology diagram (2D) and JSmol (3D) viewer that are interlinked
to show annotations in 1D, 2D and 3D.
PDB archive (as of 17 September 2015) that are classified as
transferase enzymes.
The query system uses the Apache-Solr indexing en-
gine and the additional functionality that provides ‘re-
fine query’ functionality was developed as part of the
‘BioSolr’ project. The results interface was developed us-
ing an updated version of Ajax-Solr (https://github.com/
evolvingweb/ajax-solr), a JavaScript framework for creating
user interfaces to Solr.
PDBe WEBSITE
The PDBe home page (http://pdbe.org) has also undergone
re-organisation to reflect the new developments and to con-
solidate the available functionality. The ‘PDBe services’ tab
provides direct access to the advanced PDBe tools, services
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Figure 4. The ‘macromolecule’ view of the query interface. The results show the number of unique macromolecules (in this case 2262) present in the result
set for the query ‘transferases’. A representative (or ‘best’) structure for each unique macromolecule is shown, with an image gallery highlighting the
location of the particular macromolecule within the assembly. Other instances of this macromolecule in PDB entries are listed below. This is in addition
to the traditional result interface which lists all the PDB entries that satisfy the given query criterion (≈18000 individual PDB entries in this case).
and resources and also categorises these based on a user’s
main area of interest. Each category lists the most relevant
tools and services and provides a short explanation of the
functionality available. Efforts have been made to consol-
idate all the PDBe training material and related resources
under the ‘PDBe training’ tab. The resources are categorised
to provide easy access to teaching materials and tutorials.
PDBe presentations and webinars are also made available.
FUTURE DEVELOPMENTS
The work to improve the data accessibility will continue
with the next stage focused on information related to small
molecules, binding sites, integration of data quality in-
formation for all experiment types and enhancements to
the value-added annotation by including genomic infor-
mation including variation and SNP data. PDBe has sev-
eral services that provide information on small molecules
(PDBeChem, 51) and their binding sites (PDBeMotif, 21).
These services will be refactored and integrated into the
new infrastructure to make the information more accessi-
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ble. PDBe will continue to work on improving the user in-
terfaces and querymechanisms andmaking additional data
available via the REST API to meet the needs of expert and
non-expert users alike.
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